Clin2
NCT07091500Possibly a fitRecruiting

Exercise and a weight-loss drug for people with obesity

ObesitySkeletal MuscleBrain Connectivity

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests whether combining a GLP-1 medication (a type of diabetes drug that also helps with weight loss) with an exercise program can improve physical function in people with obesity. If you are obese and have trouble with daily activities, this study may help you become more mobile and healthier.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
50 years to 75 years
Study type
Interventional

Who can take part

  • You have obesity (body mass index, or BMI, of 30 or higher).
  • You have some difficulty doing everyday physical tasks (like walking or getting up from a chair).
  • Your primary doctor has given you permission to join.
  • Your weight has been stable (not up or down more than 4%) in the last 2 months.
  • You are not already exercising for 150 minutes or more per week.
  • You do not have diabetes, serious heart or lung disease, or other major health issues listed in the full criteria.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07319975Not yet recruiting
Weight-loss drugs plus exercise for obesity

This study tests whether two weight-loss medications, semaglutide and tirzepatide, combined with an exercise program can help people with obesity lose weight. It may help you if you are looking for a structured medical approach to weight loss.

Istanbul, Zeytinburnu
NCT07770841Recruiting· Phase 3
Oral medication for weight loss study

This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.

Birmingham, Alabama
NCT06423599Recruiting· Phase 2/Phase 3
Weight Loss for Obesity and Heart Failure

This study tests whether weight loss from a medication can improve how you feel, move, and how well your heart works. It's for people who have both obesity and heart failure with reduced pumping strength.

Copenhagen
NCT07323134Not yet recruiting
Semaglutide and gut bacteria in people with obesity

This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.

NCT06885736Recruiting
Preserving muscle with exercise and protein on weight loss drugs

This trial tests whether adding resistance exercise and extra protein can help you keep your muscle while taking weight loss medications like semaglutide or tirzepatide. It is for people with a BMI of 27 or higher who are not already exercising regularly.

Kuwait City
NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.